PeerCurrent.com|Stay current with the people and research shaping what comes next.

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Researcher

Pascal Claudepierre

Inserm

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs1 Trials Reviews Guidelines

Latest

Everything in the corpus, newest first.

AUG 17, 2026 · JOURNAL ARTICLE

Risk of Cancer according to Duration of Targeted Therapy Exposure in Spondyloarthritis: A Nationwide Cohort Study from the French Health Insurance Database

Arthritis & Rheumatology

Large nationwide cohort study with 56,591 patients and 1,224 cancer events using weighted Cox models to address confounding, showing no increased cancer risk with prolonged targeted therapy exposure in spondyloarthritis.

Strong EvidenceL. Pina Vegas Pascal Claudepierre Karine Tankovic

Reported

Sample size56591

Total cancer events1224

Median follow-up (years)5.0

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support